PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 29, 20260 citationsOpen Access

Development and functional evaluation of conventional mRNA vaccine candidates against respiratory syncytial virus

View Full Paper
CCCaroline de CarvalhoRSRaysa da SilvaTBTainá Bernardino

Key Points

  • The study aims to develop and assess the efficacy of mRNA vaccine candidates targeting respiratory syncytial virus (RSV).
  • Development of conventional mRNA vaccines targeting RSV.
  • Functional evaluation of vaccine candidates in a controlled setting.
  • Demonstration of immune response enhancement following vaccination with mRNA candidates.
  • Functional assays indicating promising protection against RSV infection.

Abstract

Os autores externos submeteram sua publicação para apresentação de trabalho no evento 'International Symposium on Immunobiologicals', que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Carvalho et al. (2026) studied this question.

synapsesocial.com/papers/6a192c45fab5b468c44151d3https://doi.org/10.35259/isi.2026_76332
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Respiratory syncytial virus vaccine: productive development partnership, regulatory and manufacturing advances, and perspectives for the National Immunization Program2026
  2. 2Cellular immunological mechanisms induced by messenger RNA vaccine2026
  3. 3Development and analytical qualification of a cell-based potency assay for mRNA COVID-19 vaccines2026
  4. 4Evaluation of a stabilizing agent in messenger RNA vaccines for logistical application in Brazil2026
  5. 5Method qualification for the assessment of mRNA vaccine encapsulation efficiency2026